Propensity score-based analysis of 30-day survival in
cardiogenic shock patients supported with different microaxial left
ventricular assist devices
Gaik Nersesian*1,4, Evgenij V
Potapov*1,4, Vivian Nelki2, Julia
Stein1, Christoph Starck1,4, Volkmar
Falk1,3,4,6, Felix Schoenrath1,4,
Florian Krackhardt2, Carsten
Tschöpe*2,4,5, Frank Spillmann*2,5
1 Department of Cardiothoracic and Vascular Surgery, German Heart Center
Berlin, Berlin, Germany
2 Department of Internal Medicine and Cardiology,
Charité-Universitätsmedizin Berlin, Germany
3 Department of Cardiothoracic Surgery, Charité-Universitätsmedizin
Berlin, Corporate Member of Freie Universität Berlin,
Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin,
Germany
4 DZHK (German Centre for Cardiovascular Research), Partner Site Berlin,
Berlin, Germany;
5 Berlin Institute of Health (BIH) Berlin-Brandenburg Center for
Regenerative Therapy (BCRT), Charité-Universitätsmedizin Berlin, Campus
Virchow Klinikum, Berlin, Germany
6 Department of Health Sciences and Technology, ETH Zürich, Zürich,
Switzerland
* Authors contributed equally to the study